Schedule 13G ownership disclosure

Vor BioPharma Inc

Common Stock, $0.0001 par value per share · CUSIP: 929033207

Event date: 2025-09-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Qiming Venture Partners VIII Investments, LLC

    Shares: 414,487.00 · Class: 4.55%

  • Qiming Venture Partners VIII-HC, L.P.

    Shares: 496,272.00 · Class: 5.44%

  • Qiming GP VIII, LLC

    Shares: 414,487.00 · Class: 4.55%

  • Qiming GP VIII-HC, LLC

    Shares: 496,272.00 · Class: 5.44%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950103-25-014354
Form type
SCHEDULE 13G
Filer
Qiming Venture Partners VIII-HC, L.P.
CIK
CIK 1910025
Filed
Nov 05, 2025
Reporting period
Sep 18, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub